verapamil has been researched along with 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harada, N; Mawatari, K; Nakamura, A; Nakano, M; Nakaya, Y; Takahashi, A; Tsutsumi, K | 1 |
1 other study(ies) available for verapamil and 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide
Article | Year |
---|---|
NO-1886, a lipoprotein lipase activator, attenuates vascular smooth muscle contraction in rat aorta.
Topics: Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Benzamides; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Calcium-Calmodulin-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Activators; Flavonoids; Hypolipidemic Agents; In Vitro Techniques; Lipoprotein Lipase; Male; Muscle Contraction; Muscle, Smooth, Vascular; Organophosphorus Compounds; Phenylephrine; Potassium Chloride; Protein Kinase C; Rats; Rats, Wistar; Signal Transduction; Staurosporine; Vasoconstriction; Vasodilation; Verapamil | 2007 |